- Report
- February 2026
- 250 Pages
Global
From €4230EUR$4,490USD£3,522GBP
- Report
- February 2026
- 250 Pages
Global
From €4230EUR$4,490USD£3,522GBP
- Report
- February 2026
- 250 Pages
Global
From €4230EUR$4,490USD£3,522GBP
- Report
- September 2026
- 197 Pages
Global
From €3340EUR$3,545USD£2,781GBP
€3711EUR$3,939USD£3,090GBP
- Report
- September 2026
- 182 Pages
Global
From €3340EUR$3,545USD£2,781GBP
€3711EUR$3,939USD£3,090GBP
- Report
- September 2026
- 194 Pages
Global
From €3340EUR$3,545USD£2,781GBP
€3711EUR$3,939USD£3,090GBP
- Report
- September 2026
- 190 Pages
Global
From €3340EUR$3,545USD£2,781GBP
€3711EUR$3,939USD£3,090GBP
- Report
- January 2026
- 192 Pages
Global
From €3340EUR$3,545USD£2,781GBP
€3711EUR$3,939USD£3,090GBP
- Report
- January 2026
- 188 Pages
Global
From €3340EUR$3,545USD£2,781GBP
€3711EUR$3,939USD£3,090GBP
- Report
- January 2026
- 187 Pages
Global
From €3340EUR$3,545USD£2,781GBP
€3711EUR$3,939USD£3,090GBP
- Report
- January 2026
- 182 Pages
Global
From €4240EUR$4,500USD£3,530GBP
- Report
- November 2026
- 168 Pages
Global
From €5512EUR$5,850USD£4,589GBP
- Report
- November 2026
- 364 Pages
Global
From €5512EUR$5,850USD£4,589GBP
- Report
- November 2026
- 367 Pages
Global
From €5512EUR$5,850USD£4,589GBP
- Report
- November 2026
- 497 Pages
Global
From €5512EUR$5,850USD£4,589GBP
- Report
- November 2026
- 174 Pages
Global
From €5512EUR$5,850USD£4,589GBP
- Report
- November 2026
- 192 Pages
Global
From €5512EUR$5,850USD£4,589GBP
- Report
- November 2026
- 274 Pages
Global
From €5512EUR$5,850USD£4,589GBP
- Report
- November 2026
- 473 Pages
Global
From €5512EUR$5,850USD£4,589GBP
- Report
- November 2026
- 378 Pages
Global
From €5512EUR$5,850USD£4,589GBP

Epilepsy is a neurological disorder characterized by recurrent seizures. It affects people of all ages and is one of the most common neurological disorders worldwide. Treatment options for epilepsy include medications, lifestyle changes, and surgery. The goal of treatment is to reduce the frequency and severity of seizures.
The epilepsy market is a subset of the larger neurology market. It is composed of pharmaceutical companies, medical device companies, and other healthcare providers. Pharmaceutical companies develop and market antiepileptic drugs (AEDs) to treat epilepsy. Medical device companies develop and market devices such as vagus nerve stimulators and responsive neurostimulators to treat epilepsy. Other healthcare providers, such as neurologists, provide diagnosis and treatment of epilepsy.
Some companies in the epilepsy market include Pfizer, GlaxoSmithKline, Johnson & Johnson, Medtronic, Abbott, and UCB. Show Less Read more